N
Nan Lin
Researcher at Harvard University
Publications - 1220
Citations - 65601
Nan Lin is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 105, co-authored 687 publications receiving 54545 citations. Previous affiliations of Nan Lin include University of Michigan & Fujian Medical University.
Papers
More filters
Journal ArticleDOI
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.
Paolo Tarantino,Qingchun Jin,Nabihah Tayob,Rinath Jeselsohn,Stuart J. Schnitt,Julie Vincuilla,Toni Trent Parker,Svitlana Tyekucheva,Tianyu Li,Nan Lin,Melissa E. Hughes,Anna Weiss,Tari A. King,Elizabeth A. Mittendorf,Giuseppe Curigliano,Sara M. Tolaney +15 more
TL;DR: The results of this cohort study did not support the interpretation of ERBB2-low breast cancer as a distinct biologic subtype and suggested that, given the worse prognosis of ER-low tumors, they may be associated with confounding of prognostic analyses of ER BB2- low expression.
Journal ArticleDOI
The Weaknesses of Civic Territorial Organizations: Civic Engagement and Homeowners Associations in Urban China
TL;DR: Wang et al. as mentioned in this paper show that homeowners' civic engagement, a necessary condition for the development of homeowners associations, is inadequate across urban communities. But, the lack of awareness of partitioned property ownership, the hidden costs of civic engagement and deficiency in social capital are the main obstacles that impede homeowners' participation in neighborhood development.
Journal ArticleDOI
Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.
Elizabeth Bullitt,Nan Lin,J. Keith Smith,Donglin Zeng,Eric P. Winer,Lisa A. Carey,Weili Lin,Matthew G. Ewend +7 more
TL;DR: Study results established the feasibility of using MR angiography to quantify vessel shape changes during therapy and suggest that changes in vessel tortuosity might enable early prediction of tumor treatment response.
Journal ArticleDOI
Increased Risk of Intraoperative Awareness in Patients with a History of Awareness
Amrita Aranake,Stephen Gradwohl,Arbi Ben-Abdallah,Nan Lin,Amy Shanks,Daniel L. Helsten,David B. Glick,Eric Jacobsohn,Alex Villafranca,Alex S. Evers,Michael S. Avidan,George A. Mashour +11 more
TL;DR: Surgical patients with a history of AWR are five times more likely to experience AWR than similar patients without a historyof AWR, and further consideration should be given to modifying perioperative care and postoperative evaluation.
Journal ArticleDOI
YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
Yichao Zhao,Longwei Xu,Zhiqing Qiao,Lingchen Gao,Song Ding,Xiaoying Ying,Yuanyuan Su,Nan Lin,Ben He,Jun Pu +9 more
TL;DR: Analysis of the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an antioxidant-enriched TCM formula, on myocardial ischemia/reperfusion (MI/R) injury shows that YXS is effective in mitigating MI/R injury by suppressing mitochondrial mediated apoptosis and oxidative stress and by upregulating LXRα.